5 Simple Techniques For Arecoline
MI-CP151 was a phase 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre analyze To guage multiple intravenous doses of sifalimumab, in Grownup sufferers with dermatomyositis or polymyositis (NCT00533091). Primary trial objectives had been To guage the security and tolerability of sifalimumab in dermatomyositis or polymyos